Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CSL
CSL logo

CSL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Carlisle Companies Inc (CSL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
352.900
1 Day change
-0.01%
52 Week Range
435.920
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Carlisle Companies Inc (CSL) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently in a downtrend with technical indicators showing oversold conditions, but there are no clear positive catalysts or strong trading signals to suggest an immediate recovery. The financial performance in the latest quarter shows declining profitability, and insider selling has significantly increased, which raises concerns about confidence in the stock. While analysts have raised price targets and maintain positive ratings, the lack of recent news and weak trading sentiment make this stock a hold for now.

Technical Analysis

The stock is in a downtrend with the MACD histogram at -5.146, indicating negative momentum. RSI is at 19.09, suggesting the stock is oversold. Moving averages are converging, and the stock is trading below key support levels (S1: 377.487, S2: 366.767). The price closed at $374.78, down 3.71% in the regular market session.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
4

Positive Catalysts

  • Analysts have raised price targets recently, with Oppenheimer increasing the target to $435 and Baird to $420, citing easing macro uncertainties and robust cash generation. The stock has a 10.48% chance of increasing in the next month based on candlestick pattern analysis.

Neutral/Negative Catalysts

  • Insider selling has increased by 6608.04% over the last month, signaling a lack of confidence from company insiders. The stock has no recent positive news or event-driven catalysts. Financial performance in Q4 2025 shows declining net income (-21.60% YoY) and EPS (-14.89% YoY).

Financial Performance

In Q4 2025, revenue increased slightly by 0.43% YoY to $1.1277 billion. However, net income dropped by 21.60% YoY to $127.4 million, EPS fell by 14.89% YoY to 3.03, and gross margin decreased by 6.54% YoY to 33.75%. This indicates a decline in profitability despite stable revenue.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain an overall positive view with raised price targets from Oppenheimer ($435) and Baird ($420). However, William Blair initiated coverage with a Market Perform rating, citing fair valuation and rising competition concerns. RBC Capital upgraded the stock to Outperform, seeing a compelling investment opportunity after a recent selloff.

Wall Street analysts forecast CSL stock price to rise
4 Analyst Rating
Wall Street analysts forecast CSL stock price to rise
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 352.940
sliders
Low
356
Averages
385.33
High
400
Current: 352.940
sliders
Low
356
Averages
385.33
High
400
JPMorgan
NULL -> Overweight
maintain
$400 -> $420
AI Analysis
2026-03-09
New
Reason
JPMorgan
Price Target
$400 -> $420
AI Analysis
2026-03-09
New
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Carlisle to $420 from $400 and keeps an Overweight rating on the shares. The firm says that as macro uncertainty persists, "disciplined leaders" in the smaller cap industrial space remain well positioned for long-term growth. It adjusted price targets as part of a mid-quarter recap.
Oppenheimer
Bryan Blair
Outperform
maintain
$400 -> $435
2026-02-27
Reason
Oppenheimer
Bryan Blair
Price Target
$400 -> $435
2026-02-27
maintain
Outperform
Reason
Oppenheimer analyst Bryan Blair raised the firm's price target on Carlisle to $435 from $400 and keeps an Outperform rating on the shares after meeting with management. Although macro uncertainties linger into 2026, Carlisle faces easing comparisons, new construction headwinds may transition to tailwinds alongside a more accommodative rate path, and robust cash generation/balance sheet optionality remains supportive. Oppenheimer views Carlisle's 2026 guidance framework as reasonable, and perhaps conservative-leaning as management anticipates a continuation of still-sluggish macro conditions and modest price/cost benefit throughout the year.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CSL
Unlock Now

People Also Watch